title: Treatment of resectable gastric cancer: current standards of care.
abstract: Gastric cancer is the second leading cause of cancer death worldwide. The local surgical treatment of gastric cancer varies geographically. However, there has been a confluence of opinion regarding the optimal therapy of gastric cancer toward multimodality therapy. In the East, many clinicians pursue adjuvant chemotherapy after a D2 resection. However, in the West, clinicians use either perioperative chemotherapy or postoperative chemoradiation. It remains unclear at this time whether either perioperative approach is the optimal approach.
authors.affiliation: Georgetown University Hospital, Lombardi Comprehensive Cancer Center, Washington, DC 20007, USA. PAK109@gunet.georgetown.edu
authors.forename: Philip Abraham
authors.initials: PA
authors.lastname: Kovoor
authors.forename: Jimmy
authors.initials: J
authors.lastname: Hwang
mesh_terms: D003131:Combined Modality Therapy; D006801:Humans; D012008:Recurrence; D013274:Stomach Neoplasms / Q000188:drug therapy / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*